Dabur OncQuest launches tool for drug resistance in CML patients
Thursday, May 17, 2007 08:00 IST Our Bureau, Bangalore
Dabur OncQuest, the Indian oncology diagnostic kit major, has introduced an innovative tool for confirmation of drug resistance in Chronic Myeloid Leukaemia (CML) patients.